In addition to chemotherapy, targeted medications have been created to treat cancer. These medications only impact cancer cells, sparing normal cells. A novel targeted therapy for the treatment of acute myeloid leukaemia is called venetoclax (AML). In Finland, Venetoclax just received market
New Delhi [India], February 25 (ANI/PRNewswire): Cancer surgery experts today launched a network of hospitals across India to support a country-wide clinical trial exploring how giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back. Led by expert
Engineers at the University of Waterloo created artificial intelligence (AI) technology to predict whether chemotherapy before surgery would be beneficial for women with breast cancer.
Artificial intelligence (AI) technology has been developed by engineers at the University of Waterloo to determine whether chemotherapy before surgery would be beneficial for people with breast cancer.
Mumbai (Maharashtra) [India], February 7 (ANI/NewsVoir): The Cancer Conclave organized by Uhapo was held between oncologists, health and policy experts in order to discuss the evolution and advancement that cancer treatment has made. The virtual program began at 2:00 p.m. with an inaugural s
A recent study from Cornell University offers a new perspective on how the chemotherapy drug etoposide delays and kills vital enzymes that support the growth of cancer cells.
Researchers at the University of Iowa are developing novel, biocompatible materials that could enhance the efficacy of chemotherapy and radiation therapy for the treatment of cancer. These materials were inspired by the foam on top of lattes, as well as gummy bears and Pop Rocks sweets.
New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.
In Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma, a four-drug chemotherapy treatment led to a longer overall survival than a two-drug combination.
Chemotherapy and pembrolizumab have been approved for the treatment of women with metastatic, recurring, or persistent cervical cancer whose tumours express PD-L1. Chemotherapy can be administered with or without bevacizumab. Whether pembrolizumab in this combination provides patients with a
According to MSD, Keytruda is the first cancer immunotherapy to be approved in India for the treatment of cervical cancer and the first immunotherapy to be approved as a first-line treatment for a significant sub-group of patients, who otherwise only had the option of chemotherapy as their t
It is a fixed-dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg), and is available as a ready-to-dilute IV injection. It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV